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PHeart Rhythm Disturbances
eft Ventricular Function During
nd After Right Ventricular Pacing
aher Nahlawi, MD, Michael Waligora, MD, Stewart M. Spies, MD, Robert O. Bonow, MD, FACC,
lan H. Kadish, MD, FACC, Jeffrey J. Goldberger, MD, FACC
hicago, Illinois
OBJECTIVES The aim of this research was to evaluate right ventricular pacing effects on left ventricular
function.
BACKGROUND Right ventricular pacing alters the ventricular activation sequence and reduces left ventricular
ejection fraction (EF). It is unclear whether the observed reduction in EF can be completely
attributed to the alteration in activation sequence.
METHODS Twelve subjects (eight women), mean age 68  12 years, with transvenous dual-chamber
pacemakers, normal left ventricular function, and intact atrioventricular (AV) conduction
were studied with serial-gated blood pool studies. Left ventricular EF was measured at a fixed
rate after at least 1 week of atrial pacing only (baseline), during short-term (2 h) and mid-term
(1 week) AV sequential pacing with a short AV delay, and after short- and mid-term AV
pacing.
RESULTS Baseline EF was 66.5  4.5%. Short-term AV pacing resulted in a decrease in EF to 60.3 
5.2% (p  0.0002). After one week of AV pacing, there was a further decline in EF to 52.9
 8.3% (p  0.0001). After cessation of mid-term pacing, EF was 57.3  5.9% (p  0.0001
vs. baseline). A total of 2, 5, 8, and 24 h later, EF remained depressed (59% to 60%, p 
0.007). At 32 h, EF was 62.9  7.6% (p  0.11 compared with baseline).
CONCLUSIONS The abnormal activation sequence resulting from right ventricular pacing accounts for only
part of the reduction in EF as mid-term pacing is associated with a lower EF than short-term
pacing, and EF remains depressed after cessation of AV pacing. Changes in ventricular
function induced by right ventricular pacing may account for some of its associated adverse
effects. (J Am Coll Cardiol 2004;44:1883–8) © 2004 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.06.074Cardiology Foundation
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ht is well known that acute right ventricular pacing (VP)
lters the normal sequence of activation and may result in a
eduction of the left ventricular ejection fraction (EF) (1–3).
ecent clinical trials have highlighted the possibility that
ight VP may result in a higher incidence of congestive
eart failure in patients with depressed left ventricular
unction (4,5). Although the mechanism for the higher
See page 1889
ncidence of congestive heart failure in these studies is likely
inked to the right VP, it remains unclear whether the
bserved reduction in left ventricular EF can be completely
ttributed to the alteration in activation sequence. If this
ere the case, then the left ventricular EF would be
xpected to decrease with right VP and recover immediately
ith restoration of a normal activation sequence.
Cardiac memory describes the phenomenon of persistent
lterations in T-wave morphology or repolarization when
ormal depolarization has been restored after extended
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ersity, Chicago, Illinois. Supported in part by grant #RR-00048 from the National
enter for Research Resources, National Institutes of Health.v
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ccepted June 14, 2004.eriods of abnormal depolarization, such as right VP (6).
he electrical or repolarization changes that occur as a result
f right VP may take weeks to resolve even when the normal
epolarization has been restored. Using echocardiographic
echniques, we (7) previously demonstrated that the phe-
omenon of cardiac memory may also apply to diastolic
unction; that is, when normal depolarization has been
estored after extended periods of abnormal depolarization,
uch as right VP, persistent abnormalities in filling and
elaxation indexes of diastolic function can be demonstrated.
he present study was undertaken with the hypothesis that
ardiac memory may also apply to left ventricular systolic
unction. Specifically, we hypothesized that when normal
epolarization has been restored after extended periods of
bnormal depolarization, such as right VP, abnormalities in
eft ventricular EF may persist.
ETHODS
ubjects. Subjects were recruited from the Pacemaker
ollow-up Program at Northwestern Memorial Hospital.
ll subjects provided written, informed consent. The study
as approved by the Northwestern University Institutional
eview Board. To be eligible to participate, subjects had to
ave transvenous dual-chamber pacemakers, normal left
entricular function, sinus rhythm, and intact atrioventric-
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EF and Right Ventricular Pacing November 2, 2004:1883–8lar (AV) conduction. Right VP leads were positioned at or
ear the right ventricular apex. No subject had clinical or
lectrocardiographic evidence of ischemia. Exclusion criteria
ncluded significant arrhythmias, significant valvular heart
isease, left ventricular systolic dysfunction, hypertrophic
ardiomyopathy, prior coronary bypass or valve surgery, and
econd- or third-degree AV block.
tudy protocol. Figure 1 is a schematic illustration of the
tudy protocol. The study was designed to assess the effect
f short-term (2 h) and mid-term (1 week) VP on left
entricular systolic function during and after cessation of
P. Ventricular function was assessed by gated blood pool
tudies. All studies were done at a fixed atrial paced rate of
0 beats/min, either with intact AV conduction or with VP
s indicated (short AV delay of 100 ms). Thus, ventricular
acing throughout refers to dual chamber, AV sequential
DDD) pacing with a short AV delay. At each evaluation,
n electrocardiogram (ECG) and blood pressure were also
btained. In addition, as VP has been shown to affect
yocardial catecholamine levels and sympathetic nerve
ctivity (8,9), morning plasma catecholamine levels were
btained on each day of this study. The study was con-
ucted in the clinical research center of Northwestern
emorial Hospital.
On the initial visit (day 0), the pacemaker was pro-
rammed so that normal AV conduction would occur. In 11
ubjects, the pacemaker was programmed to atrial pacing
AAI) mode; in one subject with carotid sinus hypersensi-
ivity, it was programmed to the DDD mode with a long
V delay. In this subject, after one week of pacing in this
Abbreviations and Acronyms
AAI  atrial pacing
AV  atrioventricular
DDD  dual chamber, AV sequential pacing
ECG  electrocardiogram
EF  ejection fraction
MOST  Mode Selection Trial
MTVP  mid-term ventricular pacing
STVP  short-term ventricular pacing
VP  ventricular pacing
igure 1. Time line depicting study protocol. Electrocardiograms, blood
ressure, and gated blood pool scans were obtained at each time point
ndicated by the vertical arrows. Between studies, pacemakers were
rogrammed to result in either normal atrioventricular (AV) conduction
AAI) or ventricular pacing (DDD mode with short AV delay), as
ndicated by the programmed mode. The mode during testing is indicated1
n top. MTVPmid-term ventricular pacing for at least one week; STVP
short-term ventricular pacing for 2 h.ode, pacemaker interrogation demonstrated 3% VP.
aseline studies were performed after at least one week of
AI (day 7) to allow for normal AV conduction. All studies
ere done at a rate of 80 beats/min. Short-term ventricular
acing (STVP) studies were performed after 2 h of DDD
acing with short AV delay (100 ms) to ensure 100% VP.
entricular capture during this period was confirmed on the
CG, and the number of sensed and paced events was
etrieved from the pacemaker event counters (99% VP).
fter the 2-h STVP evaluation, pacemakers were repro-
rammed to AAI mode, and the subjects were immediately
estudied. Upon completion of the day 7 studies, subjects
ere sent home with the pacemaker programmed to the
DD mode with a short AV delay (100 ms) to ensure 100%
P. Subjects returned for evaluation after at least one week
f VP. Pacemaker interrogation confirmed 99% VP in all
ubjects. Subjects were then studied during mid-term ven-
ricular pacing (MTVP). The pacemakers were then repro-
rammed to AAI, and studies were performed immediately,
, 5, 8, 24, and 32 h after cessation of MTVP.
ated cardiac blood pool imaging. Standard multiple-
ated acquisition scans were performed at rest in the supine
osition after the injection of 20 to 25 mCi of technetium-
9m–labeled red blood cells on each of the three study days.
maging was performed with a standard Anger camera
Siemens, Hoffman Estates, Illinois) equipped with a
arallel-hole collimator oriented in a modified left anterior
blique projection to best isolate the left ventricle from
urrounding structures. A sequence of cardiac images span-
ing the cardiac cycle was constructed from several hundred
ardiac cycles by computer-based electrocardiographic gat-
ng. The ECG was monitored continuously to ensure
ppropriate gating of the QRS complex. Data were acquired
t a frame rate of 32 frames per R-R interval (approximately
3 ms/frame). All studies were performed at a fixed heart
ate (80 beats/min).
Left ventricular regions of interest were manually drawn
n systole and diastole. Global left ventricular EF was
alculated from a background-corrected time-activity curve
ccording to the formula:
left ventricular EF
(end-diastolic count end-systolic count) ⁄ end-diastolic count
lectrocardiography. Standard 12-lead ECGs (50 mm/s)
ere acquired. QRS duration was measured at baseline and
uring both short-term and MTVP.
atecholamines. Plasma epinephrine and norepinephrine
evels were measured on the morning of day 7 (baseline
alue with intact AV conduction), one week later during
TVP (day 14), and one day after the cessation of MTVP.
lood samples were drawn in the morning before the
ubject had risen from bed from an indwelling intravenous
atheter.
Blood samples were collected in heparinized tubes and
laced on ice. After centrifugation at 4°C at 3,000 rpm for
5 min, 2 ml of plasma was transferred to a tube containing
4

p
t
e
p
a
I
p
S
S
m
s
s
R
T
T
c
c
s
a
r
a
r
1
b
E
v
A
b
r
(
i
c
s
0
v
E
o
f
d
F
s
(
f
M
s
d
s
0
R
o
v
a
a
H
i
s
e
M
0
u
c
w
0
o
M
F
o
w
2
w
F
o
w
1885JACC Vol. 44, No. 9, 2004 Nahlawi et al.
November 2, 2004:1883–8 EF and Right Ventricular Pacingmg of reduced glutathione as a preservative and stored at
70°C for subsequent analysis. Catecholamine levels in
lasma were assayed by liquid chromatography with elec-
rochemical detection. The method combines liquid/liquid
xtraction of catecholamines from plasma with reversed-
hase chromatography incorporating a cation-exchange re-
gent (Plasma Catecholamine Kit; Bioanalytical Systems,
nc., West Lafayette, Indiana) (10,11) and has been used in
revious studies (12).
tatistical analysis. Data are reported as mean values  1
D. Time-dependent changes were assessed with repeated
easures analysis of variance. Post-hoc pairwise compari-
ons were done with t tests. A p value0.05 was considered
ignificant.
ESULTS
welve subjects, mean age 68  12 years, were studied.
here were eight women and four men. The indication for
ardiac pacing was sick sinus syndrome in 11 subjects, and
arotid sinus hypersensitivity in one subject. A total of four
ubjects were receiving beta-blocker therapy, one was taking
n angiotensin-converting enzyme inhibitor, and one was
eceiving antiarrhythmic drug therapy. There were no alter-
tions in medication regimens during the study period.
During each measurement of left ventricular EF, heart
ate was 80 beats/min. Baseline systolic blood pressure was
37  25 mm Hg with no significant change in systolic
lood pressure throughout the study protocol.
ffects of STVP on left ventricular EF. The baseline left
entricular EF after at least one week of AAI with normal
V conduction was 66.5  4.5%. All subjects had a normal
aseline left ventricular EF (55%). Short-term VP for 2 h
esulted in a decrease in left ventricular EF to 60.3  5.2%
p  0.0002). Immediately after discontinuing DDD pac-
ng, there was no significant change in left ventricular EF
ompared with STVP (58.2  4.8%). However, it was
ignificantly reduced compared with the baseline study (p
.0001). The QRS duration during STVP was 168 16 ms
ersus 90  16 ms at baseline (p  0.0003).
ffects of MTVP on left ventricular EF. After one week
f VP, there was a significant decline in left ventricular
unction compared with baseline. The left ventricular EF
ecreased from 66.5  4.5% to 52.9  8.3% (p  0.0001).
urthermore, the left ventricular EF during MTVP was
ignificantly lower than the left ventricular EF during STVP
p  0.0008). Figure 2 demonstrates the left ventricular EF
or each subject at baseline, during STVP, and during
TVP. A decline in EF between the STVP and MTVP
tudies was observed in 10 of the 12 subjects. The QRS
uration during MTVP was 167  16 ms, which was
ignificantly prolonged compared with baseline (p 
.0003), but similar to the QRS duration during STVP.
ecovery of left ventricular function after cessation
f VVI. Figure 3 demonstrates individual data for left
entricular EF at baseline, during MTVP, and immediately
a
cfter cessation of MTVP. An immediate increase in EF
fter cessation of MTVP occurred in 9 of 12 subjects.
owever, all subjects had a lower left ventricular EF
mmediately after cessation of VP, when the depolarization
equence had been restored to normal, than at the baseline
valuation.
The time-dependent changes in left ventricular EF due to
TVP and after cessation of MTVP were significant (p 
.0001). Immediately after cessation of MTVP, left ventric-
lar EF was 57.3  5.9%. This was significantly reduced
ompared with the baseline EF (p  0.0001). However, it
as significantly improved compared with MTVP (p 
.05). Figure 4 demonstrates the sequential measurements
f left ventricular EF during MTVP and after cessation of
TVP. At 2, 5, 8, and 24 h after cessation of MTVP, left
igure 2. Plot of individual values of left ventricular ejection fraction
btained at the baseline evaluation after at least one week of atrial pacing
ith normal atrioventricular conduction (BASE), during short-term (after
h) ventricular pacing (STVP), and during mid-term (after at least one
eek) ventricular pacing (MTVP).
igure 3. Plot of individual values of left ventricular ejection fraction
btained at the baseline evaluation after at least one week of atrial pacing
ith normal atrioventricular conduction (BASE), during mid-term (after
t least one week) ventricular pacing (MTVP), and immediately after
essation of MTVP (immediately post-MTVP).
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EF and Right Ventricular Pacing November 2, 2004:1883–8entricular EF remained depressed (between 59% to 60%)
ompared with baseline AAI (59.2 6.2%, p 0.001; 59.5
6.5%, p  0.002; 58.8  8.0%, p  0.004; 59.8  6.9%,
 0.007, respectively). At 32 h after cessation of MTVP,
he left ventricular EF was 62.9 7.6% (p 0.11 compared
ith baseline, p  0.02 compared with the EF immediately
fter cessation of MTVP).
lasma catecholamine levels. The baseline epinephrine
nd norepinephrine levels were 1.30  1.14 and 2.08 
.21 pmol/ml. After one week of AV pacing with a short
V delay, the epinephrine and norepinephrine levels were
.54  1.26 and 1.86  0.58 pmol/ml. A total of 24 h after
essation of MTVP, the epinephrine and norepinephrine
evels were 1.47  0.87 and 2.34  1.20 pmol/ml. There
ere no significant changes in plasma catecholamine levels.
ISCUSSION
ur findings suggest that abnormal activation sequence
ccounts for only part of the reduction in global left
entricular EF associated with prolonged right VP. The
bnormal activation sequence cannot completely explain the
bserved reduction because:
) There was further reduction in left ventricular EF
associated with MTVP compared with STVP despite
having the same abnormal activation sequence in both
types of studies;
) Ejection fraction did not completely recover immedi-
ately after cessation of either short-term or MTVP
despite normalization of activation sequence;
) Ejection fraction was significantly depressed compared
with baseline for at least 24 h after cessation of MTVP
igure 4. Plot of mean  SD values of left ventricular ejection fraction
btained in all 12 subjects at the baseline evaluation after at least one week
f atrial pacing with normal atrioventricular conduction (BASE), during
id-term (after at least one week) ventricular pacing (MTVP), and 0, 2, 5,
, 24, and 32 h after cessation of MTVP. *p  0.007 compared with
ASE; †p  0.02 compared with 0 h after cessation of ventricular pacing.despite restoration of a normal activation sequence. ahe effects of short-term versus MTVP on left ventricular
F and the recovery of left ventricular function after
essation of right VP have not been previously evaluated. It
s noteworthy that only 2 h of VP (short-term) led to
ersistent reduction in left ventricular EF after restoration
f a normal activation pattern. There was a gradual recovery
n EF after cessation of MTVP. By 32 h after cessation of
acing, the EF was approaching its baseline values.
ffects of VVI on left ventricular EF. Several studies of
TVP have demonstrated that even AV synchronous pacing
s associated with a statistically significant reduction in left
entricular EF compared with AAI pacing (1–3). In those
tudies, left ventricular EF and cardiac output as determined
y echocardiography, radionuclide studies, and cardiac cath-
terization were higher in the AAI mode than in the DDD
ode, likely because of the preservation of the normal
entricular activation pattern with AAI pacing. Boucher et
l. (13) reported no significant change in EF with VP,
hough 11 of 13 subjects with normal EFs did have a decline
n EF with VP. The present study confirms that VP, even in
V sequential paced mode, results in a reduction in EF.
Nielsen et al. (14) randomized patients with sick sinus
yndrome to either DDD or AAI for two years. In the AAI
roup, the left ventricular EF at baseline was 62% and
emained unchanged after two years (61%), whereas, in the
DD group, the left ventricular EF decreased from 61% at
aseline to 56% after two years of pacing (p  0.013). The
resent study confirms that prolonged VP is associated with
reduction in left ventricular EF. Furthermore, left ven-
ricular EF is reduced to a greater extent after MTVP than
ith STVP.
otential mechanisms of the effect of right VP on left
entricular function. In addition to the potential role of an
ltered sequence of activation, there are several other patho-
hysiologic alterations that have been described to occur in
he setting of VP that could contribute to or result from the
bserved decline in EF with right VP. Ventricular pacing
ffects myocardial perfusion (14–16). Nielsen et al. (14)
ound that VP reduced inferior, septal, and global mean
yocardial blood flow compared with the effects of tempo-
ary AAI pacing in the same subjects.
Lee et al. (8) studied 16 dogs with iatrogenic complete
V block and found that cardiac tissue norepinephrine
evels were significantly increased in the ventricular paced
roup compared with controls. Although no change in
lasma catecholamines were noted in this study, it remains
ossible that testing peripheral catecholamine levels is not
ensitive enough to detect changes in myocardial catechol-
mine levels or small changes in sympathetic nerve activity.
eightened sympathetic activity would likely be secondary
o the decline in EF, rather than the primary cause.
Karpawich et al. (17), in a histopathologic study on the
ffects of epicardial permanent right VP on canine hearts,
ound evidence of myofibrillar cellular disarray, dystrophic
alcifications, prominent subendocardial Purkinje cells, and
n increase in variable-sized, disorganized mitochondria. In
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November 2, 2004:1883–8 EF and Right Ventricular Pacingnother study (18), pacing for three months from the right
entricular apex in dogs with iatrogenic complete AV block
aused myofibrillar disarray in 9 of 12 dogs in the paced
roup and none in the control group.
ffects of VP on postpacing left ventricular EF. Any of
he mechanisms described above may be implicated in the
ostpacing depression of the EF. Ventricular pacing is also
nown to cause secondary changes in repolarization after
essation of pacing, a phenomenon known as cardiac mem-
ry (6). Recent investigation into this phenomenon has
dentified specific ion channels that are modified as a result
f VP, such as the calcium-insensitive transient outward
urrent (Ito) (19) and the L-type calcium current (20).
urthermore, it has been shown that administration of the
rotein synthesis inhibitor cycloheximide before pacing
arkedly and reproducibly attenuates the evolution of
ardiac memory (21). These data suggest that VP induces
hanges in cardiac ion channel function that persist when
acing is stopped, manifest as cardiac memory. Spragg et al.
22) provided further evidence that altered activation se-
uence may induce regional changes in protein expression
hat may have adverse effects on ventricular function in a
anine tachycardia-induced heart failure model.
tudy limitations. The present study focused on determi-
ation of global left ventricular EF during and after periods
f right VP. We have previously shown using echocardio-
raphic techniques that diastolic function abnormalities may
lso persist after cessation of right VP (7). Further studies
ill need to address the interdependence of these diastolic
nd systolic functional abnormalities. In addition, regional
nalysis of diastolic and systolic function in relation to
acing site may be useful in assessing the optimal sites for
P (i.e., those that have the least negative effect on regional
nd global diastolic and systolic function). Finally, this study
tilized a very short AV delay to guarantee 100% VP. It is
ossible that some of the noted abnormalities could be
elated to this “unphysiologic” AV delay.
mplications. A Danish randomized clinical trial of 225
atients with sick sinus syndrome showed that AAI pacing
s associated with significantly lower death rates, atrial
brillation, thromboembolic complications, and heart fail-
re (23) than VVI pacing. Yet, three large-scale North
merican trials (Pacemaker Selection in the Elderly
PASE], Canadian Trial Of Physiologic Pacing [CTOPP],
ode Selection Trial [MOST]), including 3,891 patients,
emonstrated no difference in mortality between DDD and
VI pacing, with only minimal differences in outcomes
etween the treatment groups (24–26). The main difference
etween the North American and the Danish trials is the
se of DDD (AV) pacing in the former and AAI pacing in
he latter as the physiologic pacing treatment arm. It is
nteresting to note that patients with DDD pacemakers are
ery frequently paced in the ventricle, despite programming
long” AV delays and underlying intact AV conduction
27). It is, therefore, plausible that the benefit of AAI over
VI pacing is due to the absence of VP rather than theresence of AV synchrony, as DDD pacing preserves the
atter but not the former.
The potential deleterious effects of right VP were recently
ighlighted in several recent reports in which an increased
ncidence of symptomatic congestive heart failure was noted
n patients who were exposed to VP. In the Multicenter
utomatic Defibrillator Implantation II trial (MADIT II)
4), the incidence of new or worsened heart failure was
4.9% in the control group versus 19.9% in those implanted
ith a device (p  0.09). It is plausible that the increased
eart failure was due to “inadvertent” right VP that might
ccur in patients with an implantable defibrillator. Support-
ng this concept, Saad et al. (28) recently reported worsen-
ng symptoms of congestive heart failure in 44% of those
atients who received an implantable defibrillator and were
xposed to right VP compared with 5% of those not exposed
o VP (p 0.01). In MOST (29), the cumulative percent of
P obtained from stored pacemaker data was a strong
redictor of heart failure hospitalizations. Finally, the Dual
hamber and VVI Implantable Defibrillator trial (DAVID)
5) demonstrated that patients undergoing defibrillator
mplantation who do not also have indications for antibra-
ycardia pacing had a higher incidence of the combined end
oint of mortality and first hospitalization for heart failure
hen their devices were programmed to dual-chamber
ate-responsive pacing rather than ventricular back-up pac-
ng at 40 beats/min. This adverse outcome was felt to be
elated to right VVI that was observed in the dual-chamber
acing group.
onclusions. Right VP appears to have a modest depres-
ant effect on left ventricular function due to underlying
hanges in intrinsic myocardial contractile properties. Fur-
her work is necessary to identify the underlying pathophys-
ologic changes responsible for the decline in left ventricular
unction. Concerted efforts should be made to maintain the
ormal activation sequence, when possible, in patients with
acemakers. Further work is necessary to define the optimal
acing site in patients who do require VP.
eprint requests and correspondence: Dr. Jeffrey J. Goldberger,
orthwestern University Medical School, Division of Cardiac
lectrophysiology, 251 East Huron, Feinberg Pavilion 8-542,
hicago, Illinois 60611. E-mail: j-goldberger@northwestern.edu.
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